Neurological Surgery Doctors in Gilbert, AZ Accepting Medicare

3 Neurological Surgery doctors found. Showing 1 - 3

David Aaron Wilson, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 3420 S Mercy Rd Ste 221, Gilbert, AZ 85297 Phone: 480-681-7374    Fax: 602-294-8297

Andrew K Metzger, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 3420 S Mercy Rd Ste 221, Gilbert, AZ 85297 Phone: 480-681-7374    Fax: 480-883-0514

Dr. Robert Mawunyo Koffie, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1757 E Baseline Rd Ste 131, Gilbert, AZ 85233 Phone: 480-999-5248    Fax: 480-999-5285

News Archive

Vitamin E has potential benefit in fighting colds in the elderly

Vitamin E supplementation has potential benefit in fighting upper respiratory tract infections such as colds in the elderly, says a study published in the Aug. 18 issue of JAMA.

Study: T cells play a vital role in controlling SARS-CoV-2 during acute phase of infection

Ever since SARS-CoV-2 first appeared, researchers have been trying to understand whether sometimes the immune system does more harm than good during the acute phase of COVID-19. The latest study by researchers at La Jolla Institute for Immunology clearly argues in favor of the immune system.

Companies pan for marketing gold in vaccines

For a decade, Jennifer Crow has taken care of her elderly parents, who have multiple sclerosis. After her father had a stroke in December, the family got serious in its conversations with a retirement community — and learned that one service it offered was covid-19 vaccination.

Authors highlight importance of body fluid recovery after training session in sports persons

Top sports persons must always perform to their maximum capacity, making them the most vulnerable to the effects of dehydration. Now, a new study conducted by researchers from the Universidad de Castilla la Mancha (UCLM) reveals that 91% of professional basketball, volleyball, handball and football players are dehydrated when they begin their training sessions.

Merck proposes to initiate Phase II proof-of-concept clinical study of posaconazole for chronic Chagas disease

Merck today announced plans to initiate a Phase II investigational proof-of-concept clinical study to evaluate its oral antifungal agent posaconazole for the treatment of chronic Chagas disease. Chagas disease results from infection with the parasite Trypanosoma cruzi that is spread by biting insects. The disease is estimated to affect approximately eight million people in Latin America, of whom approximately 30-40 percent will develop serious cardiac disease, digestive disease, or both as a result of this infection.

Read more Medical News

› Verified 9 days ago